Alkem Laboratories has a strong commitment towards manufacturing quality products. The safety of pharmaceutical product may not be distinct, post effects of drug when used in combination of other drugs are generally unknown and safety concerned in different groups can be different as in young children, elderly patient, pregnant women. Therefore to monitor the safety of its product when the product is available for clinical practice, Alkem has moral and regulatory responsibility to conduct Pharmacovigilance activities.
Alkem Laboratories has pharmacovigilance system to safeguard the patient health through efficient and timely identification, collection, assessment, and communication of medicine-related adverse events.
What is Pharmacovigilance
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of side effects or any other possible drug related problems.
Check: Alkem's Pharmacovigilance Policy
An adverse event is any untoward medical occurrence in a patient following administration of a pharmaceutical product and which does not necessarily have a causal relationship with the administered product.
If you wish to report a suspected adverse reaction/side effect occurred with our drug, you can do so by choosing any of the following options:
Download Adverse Event Reporting Form
(If you have any query in filling the form click here to download the guidance document)
Alkem Laboratories Ltd.
Global Pharmacovigilance Cell (Medical Department)
Alkem Laboratories Limited
Office No G/4, Empire Complex,
414, Senapati Bapat Marg,
Lower Parel, Mumbai - 400013.
ADR Reporting Toll-Free Number: 1800-22-99-10
Email: pvglobal@alkem.com
For more information about our products you can call us at 1800-22-99-10 (toll- free number), Monday to Friday between 9:30 am to 5:30 pm
General Disclaimer :
“Although every efforts are being made to put the most updated information, there may be a time gap between the generation of new information and date of product update.”